¿Debemos seguir usando montelukast en pediatría?
Neumol. pediátr. (En línea); 19 (3), 2024
Results: 5
Solid Phase Extraction and Simultaneous Chromatographic Quantification of some Non-steroidal Anti-inflammatory Drug Residues; an Application in Pharmaceutical Industrial Wastewater Effluent
Braz. J. Pharm. Sci. (Online); 58 (), 2022
Abstract Two sensitive and selective methods were developed for the simultaneous determination of four commonly used non-steroidal anti-inflammatory drugs (NSAIDs), namely; paracetamol (PCM), diclofenac sodium (DCF), ibuprofen (IBP), and indomethacin (IND) in wastewater effluents. The first method used ...
Dissolution profile of different brands of low solubility drugs available in the Nigerian and Brazilian pharmaceutical markets
The purpose of this work was to elaborate a diagnosis of the dissolution test in Africa in comparison with Brazil, evaluating the dissolution profile of low solubility drugs such as albendazole, ibuprofen, furosemide, glibenclamide, hydrochlorothiazide and carvedilol to ascertain their quality. The disso...
Reacciones adversas a montelukast: de la teoría a la práctica. Serie de casos
Arch. argent. pediatr; 119 (4), 2021
El montelukast se utiliza ampliamente en el tratamiento de sibilancias recurrentes y/o asma. Están descritas
numerosas reacciones adversas medicamentosas (RAM) en niños relacionadas con montelukast; se destacan las neuropsiquiátricas. Realizamos un estudio observacional, retrospectivo, descriptivo, so...
Antagonistas de Leucotrieno/efectos adversos, Trastornos del Sueño-Vigilia/inducido químicamente, Acetatos/efectos adversos, Ciclopropanos/efectos adversos, Quinolinas/efectos adversos, Sulfuros/efectos adversos, Antiasmáticos/efectos adversos, Asma/tratamiento farmacológico, Estudios Retrospectivos
Development and validation of highly selective method for the determination of imatinib mesylate and dexketoprofen trometamol combination in three different media
Braz. J. Pharm. Sci. (Online); 56 (), 2020
Imatinib mesylate is a small molecule used in cancer therapy as a thyrosine kinase inhibitor. Dexketoprofen trometamol is a non-steroidal anti-inflammatory drug that has seen use in cancer therapy in combination with an anticancer drug to minimize tumor size and to reduce pain in patients. In the present...